FindMyKOL
Clinical trialNCT06051890RecruitingPhase 4Interventional

Assessing Optimal XRB Initiation Points in Jail

SponsorNYU Langone HealthEnrollment50Opioid Use Disorder
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This application describes a 3-year, randomized controlled trial. Eligible, consenting adults (N=200) with existing sublingual buprenorphine (SLB) prescriptions who enter Middlesex County House of Corrections (MCHOC) as pre-trial detainees will be randomized at admission on a 1:1 basis to be inducted onto extended-release buprenorphine (XRB) at the time of admission (experimental condition) or remain in SLB (E-TAU; all participants will also receive naloxone). The two approaches will be compared with regard to (1) the percentage of participants released from jail with at least 7 days of buprenorphine in their system, (2) percentage of participants continuing MOUD treatment in the community, and (3) infractions related to buprenorphine diversion.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Tufts University Health Sciences

    Boston, Massachusetts, United States

    Thomas Stopka, Ph.D.
    Recruiting
  • Baystate Health

    Springfield, Massachusetts, United States

    Peter Friedmann, MD
    Recruiting
  • Middlesex County House of Corrections

    New Brunswick, New Jersey, United States

    Kashif Siddiqi
    Recruiting
  • Nyu Langone Health - 180 Madison Ave

    New York, New York, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Extended-Release BuprenorphineSublingual Buprenorphine
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Jun 2025
Primary completion
1 Dec 2026
Completion
1 Mar 2027
Last update posted
7 Aug 2026
Registered enrollment
50
Registry id
NCT06051890
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.